Australie - anglais - Department of Health (Therapeutic Goods Administration)

global medical solutions australia pty limited - thallous(201tl) chloride, quantity: 74 mbq/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid; benzyl alcohol - thallous [201tl] chloride injection may be useful in myocardial perfusion imaging and for the diagnosis and localization of myocardial infarction. it may also be useful in conjunction with exercise stress testing as an adjunct to the diagnosis of ischemic heart disease. thallous [201tl] chloride injection may be useful for the localization of areas of parathyroid hyperactivity and for parathyroid imaging in patients with biochemically proven hyper-parathyroidism.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

australian nuclear science and technology organisation t/a ansto - gallium (67ga) citrate, quantity: 100 mbq/ml - injection, solution - excipient ingredients: benzyl alcohol; sodium hydroxide; sodium citrate dihydrate; water for injections - (as per r46108) gallium (67ga) citrate injection bp may be useful in demonstrating the presence and extent of hodgkin's disease, lymphomas and bronchogenic carcinoma. positive intake in the absence of prior symptoms may indicate a potential disease state. new indications as specified in the letter of 18 october 1993 from dr alex proudfoot: gallium (67ga) citrate injection bp may be useful in demonstrating the presence and extent of hodgkin's disease, lymphomas and bronchogenic carcinoma. positive uptake in the absence of prior symptoms may indicate a potential disease state. gallium (67ga) may also be useful as an aid in detecting some acute inflammatory lesions. gallium (67ga) citrate injection bp may also be useful as an aid in detecting some acute inflammatory lesions. (as per r46110) gallium (67ga) citrate injection bp may be useful in demonstrating the presence and extent of hodgkin's disease, lymphomas and bronchogenic carcinoma. positive uptake in the absence of prior symptoms may indicate a potent

Canada - anglais - Health Canada

curium canada inc - gallium citrate ga 67 - solution - 74mbq - gallium citrate ga 67 74mbq - roentgenography

États-Unis - anglais - NLM (National Library of Medicine)

ucla biomedical cyclotron - gallium ga-68 gozetotide (unii: zj0ekr6m10) (gallium ga-68 gozetotide - unii:zj0ekr6m10) - gallium ga 68 gozetotide injection is indicated for positron emission tomography (pet) of prostate-specific membrane antigen (psma) positive lesions in men with prostate cancer: - with suspected metastasis who are candidates for initial definitive therapy. - with suspected recurrence based on elevated serum prostate-specific antigen (psa) level. none risk summary gallium ga 68 gozetotide injection is not indicated for use in females. there are no available data with gallium ga 68 gozetotide injection use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. all radiopharmaceuticals, including gallium ga 68 gozetotide injection, have the potential to cause fetal harm depending on the fetal stage of development and the magnitude of the radiation dose. animal reproduction studies have not been conducted with gallium ga 68 gozetotide. risk summary gallium ga 68 gozetotide injection is not indicated for use in females. there are no data

États-Unis - anglais - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - amiodarone hydrochloride (unii: 976728sy6z) (amiodarone - unii:n3rq532iut) - amiodarone hydrochloride 100 mg - amiodarone hydrochloride tablets are indicated for the treatment of documented, life-threatening recurrent ventricular fibrillation and life-threatening recurrent hemodynamically unstable tachycardia in adults who have not responded to adequate doses of other available antiarrhythmics or when alternative agents cannot be tolerated. - cardiogenic shock. - sick sinus syndrome, second- or third-degree atrioventricular block, bradycardia leading to syncope without a functioning pacemaker. - known hypersensitivity to the drug or to any of its components, including iodine. risk summary available data from postmarketing reports and published case series indicate that amiodarone use in pregnant women may increase the risk for fetal adverse effects including neonatal hypo- and hyperthyroidism, neonatal bradycardia, neurodevelopmental abnormalities, preterm birth and fetal growth restriction. amiodarone and its metabolite, desethylamiodarone (dea), cross the placenta. untreated underlying arrhythmias, including ventric

États-Unis - anglais - NLM (National Library of Medicine)

apotex corp - amiodarone hydrochloride (unii: 976728sy6z) (amiodarone - unii:n3rq532iut) - amiodarone hydrochloride 200 mg - amiodarone hydrochloride tablets are indicated for the treatment of documented, life-threatening recurrent ventricular fibrillation and life-threatening recurrent hemodynamically unstable tachycardia in adults who have not responded to adequate doses of other available antiarrhythmics or when alternative agents cannot be tolerated. - cardiogenic shock. - sick sinus syndrome, second- or third-degree atrioventricular block, bradycardia leading to syncope without a functioning pacemaker. - known hypersensitivity to the drug or to any of its components, including iodine. risk summary available data from postmarketing reports and published case series indicate that amiodarone use in pregnant women may increase the risk for fetal adverse effects including neonatal hypo- and hyperthyroidism, neonatal bradycardia, neurodevelopmental abnormalities, preterm birth and fetal growth restriction. amiodarone and its metabolite, desethylamiodarone (dea), cross the placenta. untreated underlying arrhythmias, including ventric

États-Unis - anglais - NLM (National Library of Medicine)

eon labs, inc. - amiodarone hydrochloride (unii: 976728sy6z) (amiodarone - unii:n3rq532iut) - amiodarone hydrochloride 200 mg - amiodarone hydrochloride is indicated for the treatment of documented, life-threatening recurrent ventricular fibrillation and life-threatening recurrent hemodynamically unstable tachycardia in adults who have not responded to adequate doses of other available antiarrhythmics or when alternative agents cannot be tolerated. risk summary available data from postmarketing reports and published case series indicate that amiodarone use in pregnant women may increase the risk for fetal adverse effects including neonatal hypo- and hyperthyroidism, neonatal bradycardia, neurodevelopmental abnormalities, preterm birth and fetal growth restriction. amiodarone and its metabolite, desethylamiodarone (dea), cross the placenta. untreated underlying arrhythmias, including ventricular arrhythmias, during pregnancy pose a risk to the mother and fetus (see clinical considerations). in animal studies, administration of amiodarone to rabbits, rats, and mice during organogenesis resulted in embryofetal toxicity at doses less tha

Australie - anglais - Department of Health (Therapeutic Goods Administration)

australian nuclear science and technology organisation t/a ansto - thallous(201tl) chloride, quantity: 125 mbq/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; benzyl alcohol - thallous chloride (201tl) may be useful in myocardial perfusion imaging for the diagnosis and localization of myocardial infarction. it may also be useful in conjunction with exercise stress testing as an adjunct in the diagnosis of ischaemic heart disease (atherosclerotic coronary artery disease).

Australie - anglais - Department of Health (Therapeutic Goods Administration)

landauer radiopharmaceuticals pty ltd - gallium (67ga) citrate -

Australie - anglais - Department of Health (Therapeutic Goods Administration)

landauer radiopharmaceuticals pty ltd - gallium (67ga) citrate -